VisionPoint Advisory Group’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-106
Closed -$11.5K 803
2024
Q2
$11.5K Hold
106
﹤0.01% 478
2024
Q1
$14K Buy
106
+3
+3% +$375 0.01% 424
2023
Q4
$12.5K Sell
103
-103
-50% -$11.5K ﹤0.01% 398
2023
Q3
$23.2K Buy
206
+103
+100% +$13.1K 0.01% 353
2023
Q2
$15K Buy
+103
New +$14K 0.01% 343

Other funds holding ZBH

VisionPoint Advisory Group's ZBH Position: Q3 2024 in Review

VisionPoint Advisory Group sold out of Zimmer Biomet (ZBH) in Q3 2024, closing a stake of 106 shares — an estimated $11.5K sold.

VisionPoint Advisory Group first reported a position in ZBH in Q2 2023 and held it in 5 quarters. The position peaked at $23.2K in Q3 2023. 981 funds tracked by Wall St. Rank hold ZBH as of Q3 2024.

  • VisionPoint Advisory Group reported no remaining Zimmer Biomet position as of Q3 2024 after selling out during the quarter.
  • VisionPoint Advisory Group sold 106 Zimmer Biomet shares in Q3 2024, an estimated $11.5K.
  • VisionPoint Advisory Group first reported a position in Zimmer Biomet in Q2 2023 and held it in 5 quarters.
  • VisionPoint Advisory Group's Zimmer Biomet position peaked at $23.2K in Q3 2023.
  • 981 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2024.

Based on VisionPoint Advisory Group's 13F filing for Q3 2024, filed 15 Oct 2024.